Obelab Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $100K
Latest Deal Amount
  • Investors
  • 6

Obelab General Information


Developer of an imaging device designed to make brain monitoring accessible. The company's device is portable, wireless and offers photogrammetry, motion calibration and digital signal processing, enabling medical professionals to monitor concussions, chronic depression, post-traumatic stress disorders (PTSD) and neurorehabilitation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • 12F Vision Tower,312
  • Teheran-ro Gangnam-gu
  • Seoul, 06211
  • South Korea
+82 00-0000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Obelab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Aug-2016 $100K 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Feb-2016 00.000 000.00 Completed Generating Revenue
1. Early Stage VC 01-Jan-2015 $50M $50M Completed Generating Revenue
To view Obelab’s complete valuation and funding history, request access »

Obelab Executive Team (4)

Name Title Board Seat Contact Info
Wonsun Chung Chief Executive Officer
Hanseok Yun Chief Operating Officer
Hyeon-Min Bae Ph.D Co-Founder & Chief Technical Officer
To view Obelab’s complete executive team members history, request access »

Obelab Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UCSF Medical Center Corporation 000 0000 000000 0
InterVest Venture Capital Minority 000 0000 000000 0
Kakao Ventures Venture Capital Minority 000 0000 000000 0
LB Investment Venture Capital Minority 000 0000 000000 0
KITE Entrepreneurship Foundation Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »